Leader
|
|
|
00000cz a2200037n 45 0 |
001
|
|
|
SUDOC|075433125
(VIAF cluster)
(Authority/Source Record)
|
005
|
|
|
202004041251.3 |
008
|
|
|
031203 nfazznn||| |n aaa |d |
003
|
|
|
SUDOC |
035
|
|
|
‡a
(SUDOC)075433125
|
024
|
7 |
|
‡a
0000000045781139
‡2
isni
|
035
|
|
|
‡a
http://viaf.org/viaf/21807660
|
100
|
1 |
|
‡a
Lloyd, Andrew W.
|
665
|
|
|
‡a
En poste: School of pharmacy and biomolecular sciences, University of Brighton, Grande-Bretagne (en 2001)
|
670
|
|
|
‡a
Drug delivery and targeting / ed. by Hillery, Lloyd, Swarbrick, 2001
|
901
|
|
|
‡a
978041527198
‡9
1
|
901
|
|
|
‡a
978041527197
‡9
1
|
909
|
|
|
‡a
(isni) 0000000045781139
‡9
1
|
910
|
|
|
‡a
drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists
‡A
Drug delivery and targeting for pharmacists and pharmaceutical scientists /
‡l
eng
‡9
1
|
919
|
|
|
‡a
drugdeliveryandtargeting
‡A
Drug delivery and targeting
‡9
1
|
920
|
|
|
‡a
978-041
‡9
1
|
921
|
|
|
‡a
taylor & francis
‡b
Taylor & Francis,
‡9
1
|
922
|
|
|
‡a
uk
‡b
gb
‡9
1
|
940
|
|
|
‡a
eng
‡9
1
|
941
|
|
|
‡a
editeur scientifique
‡e
Éditeur scientifique
‡9
1
|
943
|
|
|
‡a
200x
‡9
1
|
944
|
|
|
‡a
am
‡9
1
|
950
|
|
|
‡a
swarbrick james
‡A
Swarbrick, James
‡d
(1934-....).
‡9
1
|
950
|
|
|
‡a
hillery anya m
‡A
Hillery, Anya M..
‡9
1
|
996
|
|
|
‡2
WKP|Q21077159
|
996
|
|
|
‡2
WKP|Q44958229
|
996
|
|
|
‡2
ISNI|0000000063787016
|
996
|
|
|
‡2
NTA|339351764
|
996
|
|
|
‡2
ISNI|0000000383504548
|
996
|
|
|
‡2
NLA|000035413033
|
996
|
|
|
‡2
WKP|Q92065690
|
996
|
|
|
‡2
LC|nb 90198010
|
996
|
|
|
‡2
JPG|500356970
|
996
|
|
|
‡2
RERO|A022518219
|
996
|
|
|
‡2
LC|no2019190375
|
996
|
|
|
‡2
ISNI|0000000038915856
|
996
|
|
|
‡2
BIBSYS|15320
|
996
|
|
|
‡2
WKP|Q56256915
|
996
|
|
|
‡2
WKP|Q21456728
|
996
|
|
|
‡2
DNB|137506260
|
996
|
|
|
‡2
LC|n 77008998
|
996
|
|
|
‡2
WKP|Q4757781
|
996
|
|
|
‡2
WKP|Q5322143
|
996
|
|
|
‡2
CAOONL|ncf10208796
|
996
|
|
|
‡2
CAOONL|ncf10014652
|
996
|
|
|
‡2
LC|n 92020523
|
996
|
|
|
‡2
LC|n 2003127934
|
996
|
|
|
‡2
WKP|Q60444303
|
996
|
|
|
‡2
WKP|Q56642608
|
996
|
|
|
‡2
BIBSYS|6004231
|
996
|
|
|
‡2
WKP|Q129691202
|
996
|
|
|
‡2
LC|n 87812900
|
996
|
|
|
‡2
RERO|A024540536
|
996
|
|
|
‡2
RERO|A003526756
|
996
|
|
|
‡2
WKP|Q4760957
|
996
|
|
|
‡2
WKP|Q57893446
|
996
|
|
|
‡2
DNB|123894670
|
996
|
|
|
‡2
WKP|Q4757779
|
996
|
|
|
‡2
LC|nb 99124555
|
996
|
|
|
‡2
N6I|vtls001324119
|
996
|
|
|
‡2
ISNI|0000000055549368
|
996
|
|
|
‡2
LC|n 2009185070
|
996
|
|
|
‡2
ISNI|0000000042816404
|
996
|
|
|
‡2
ISNI|0000000030797568
|
996
|
|
|
‡2
PLWABN|9810648199105606
|
996
|
|
|
‡2
WKP|Q4760958
|
996
|
|
|
‡2
LC|n 88094359
|
996
|
|
|
‡2
ISNI|0000000073413616
|
996
|
|
|
‡2
WKP|Q2846365
|
996
|
|
|
‡2
DBC|87097968642086
|
996
|
|
|
‡2
ISNI|0000000428966026
|
996
|
|
|
‡2
DBC|87097991395487
|
996
|
|
|
‡2
BIBSYS|1535375968251
|
996
|
|
|
‡2
ISNI|0000000057179145
|
996
|
|
|
‡2
NSK|000088835
|
996
|
|
|
‡2
J9U|987007322985105171
|
996
|
|
|
‡2
LC|nb2003036362
|
996
|
|
|
‡2
ISNI|0000000476916808
|
996
|
|
|
‡2
WKP|Q2053081
|
996
|
|
|
‡2
BIBSYS|90300653
|
996
|
|
|
‡2
WKP|Q58176723
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Lloyd, Andrew W.
‡2
LC|no2002029608
‡3
exact title: (1.00, 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists', 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists')
|
998
|
|
|
‡a
Lloyd, Andrew W.
‡2
BIBSYS|2014575
‡3
viafid
‡3
standard number
|
998
|
|
|
‡a
Lloyd, Andrew W.
‡2
J9U|987007343425105171
‡3
exact title: (1.00, 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists', 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists')
‡3
viafid
|
998
|
|
|
‡a
Lloyd, Andrew W.
‡2
ISNI|0000000045781139
‡3
suggested
‡3
joint author: (1.00, 'hillery anya m', 'hillery anya m')
|
998
|
|
|
‡a
Lloyd, Andrew W.
‡2
CAOONL|ncf11342685
‡3
exact title: (1.00, 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists', 'drugdeliveryandtargetingforpharmacistsandpharmaceuticalscientists')
|
999
|
|
|
‡2
SUDOCBIB|059784474
|